SFX by Ex Libris Inc.

Title:	Financing Immunization of Adults in the United States
Source:	Clinical Pharmacology & Therapeutics [0009-9236] Orenstein, W A yr:2007

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Hinman, A R R. "Addressing the Vaccine Financing Conundrum." Health affairs 24.3: 701-4.
description	2.	Coleman, Margaret S. "Net financial gain or loss from vaccination in pediatric medical practices." Pediatrics 124.Supplement (2009): 472-91.
description	3.	Nichol, Michael L. "Cost effectiveness of influenza vaccination for healthy persons between ages 65 and 74 years." Vaccine 20.2 (2002): 21-4.
description	4.	Anis, E. "A cluster of deaths following influenza vaccination, Israel, 2006." Journal of Public Health Policy 31.3 (2010): 318-323.
description	5.	Davis, Matthew M M. "Childhood vaccine purchase costs in the public sector: past trends, future expectations." American Journal of Public Health 92.12 (2002): 1982-7.
description	6.	Barker, J P H. "Influenza vaccination of elderly persons. Reduction in pneumonia and influenza hospitalizations and deaths." JAMA 244.22 (1980): 2547-2549.
description	7.	Berman, S. "Is Our Vaccine System at Risk for a Future Financial "Meltdown?"." Pediatrics 122.6 (2008): 1372-1373.
description	8.	Kaddar, M. "Financial challenges of immunization: a look at GAVI." Bulletin of the World Health Organization 82.9 (2004): 697-702.
description	9.	Wang, Chong-Shan S. "Efficacy and cost-effectiveness of influenza vaccination of the elderly in a densely populated and unvaccinated community." Vaccine 20.19-20 (2002): 2494-9.
description	10.	Mullahy, J. "It'll only hurt a second? Microeconomic determinants of who gets flu shots." Health economics 8.1 (1999): 9-24.
description	11.	Hinman, R. "Financing Vaccines in the 21st Century : Recommendations from the National Vaccine Advisory Committee." American journal of preventive medicine 29.1 (2005): 71-75.
description	12.	Smith, Philip J. "Associations Between Childhood Vaccination Coverage, Insurance Type, and Breaks in Health Insurance Coverage." Pediatrics 117.6 (2006): 1972-1978.
description	13.	Freed, Gary L. "Role of health insurance and a usual source of medical care in age-appropriate vaccination." American journal of public health 94.6 (2004): 960-6.
description	14.	Largeron, S. "The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: A model-based analysis for Spain." Vaccine 25.39-40 (2007): 6900-6910.
description	15.	Cipriano, Lauren E. "The Cost-Effectiveness of Expanding Newborn Screening for up to 21 Inherited Metabolic Disorders Using Tandem Mass Spectrometry: Results from a Decision-Analytic Model." Value in health 10.2 (2007): 83-116.
description	16.	Parente, Stephen T T. "The role of consumer knowledge of insurance benefits in the demand for preventive health care among the elderly." Health economics 14.1 (2004): 25-38.
description	17.	Hebert, L. "The Causes of Racial and Ethnic Differences in Influenza Vaccination Rates among Elderly Medicare Beneficiaries." Health services research 40.2 (2005): 517-37.
description	18.	Kremer, M. "Creating markets for new vaccines. Part I: rationale." Innovation policy and the economy 1 (2000): 35-72.
description	19.	Hueston, William J. "Does having a personal physician improve quality of care in diabetes?" Journal of the American Board of Family Medicine (formerly Journal of the American Board of Family Practice) 23.1 (2010): 82-87.
description	20.	Lieu, T. "Vaccine Financing in the United States An Emerging Crisis." Archives of pediatrics & adolescent medicine 163.5 (2009): 485-487.